Encompass Health (NYSE: EHC) director gets 29 dividend-linked RSUs credited

Rhea-AI Filing Summary

CARMICHAEL GREG D reported acquisition or exercise transactions in this Form 4 filing.

Encompass Health Corp director Greg D. Carmichael received an automatic award of 29 restricted stock units (RSUs) tied to a common stock dividend paid on July 15, 2026. These RSUs were credited at a dividend of $0.19 per share and a closing price of $109.88, bringing his reported direct Encompass Health equity holdings to 20,349 units.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider CARMICHAEL GREG D

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Encompass Health Common Stock	29	$0.00	--

Holdings After Transaction: Encompass Health Common Stock — 20,349 shares (Direct)

Footnotes (1)

1. [object Object]

Key Figures

RSUs awarded: 29 RSUs Holdings after transaction: 20,349 units Dividend per share: $0.19 per share +1 more

4 metrics

RSUs awarded 29 RSUs Automatic dividend-equivalent award to non-employee director on July 15, 2026

Holdings after transaction 20,349 units Total Encompass Health equity holdings reported for Greg D. Carmichael following the RSU award

Dividend per share $0.19 per share Cash dividend on Encompass Health common stock paid July 15, 2026

Closing price $109.88 Closing price of Encompass Health common stock on the July 15, 2026 dividend payment date

Key Terms

restricted stock units, dividend record date, closing price, non-employee director

4 terms

restricted stock units financial

"additional restricted stock units ("RSUs") are credited to each non-employee director's account"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

dividend record date financial

"number of the RSUs in each director's account on the associated dividend record date"

closing price financial

"divided by (b) the closing price on the dividend payment date"

non-employee director financial

"RSUs are credited to each non-employee director's account in connection with common stock dividend payments"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/16/2026 - 04:09 PM Accepted by SEC EDGAR 07/16/2026 - 04:09 PM Learn about SEC filing dates

FAQ

What insider transaction did Encompass Health (EHC) report for Greg D. Carmichael?

Encompass Health director Greg D. Carmichael received an automatic award of 29 restricted stock units (RSUs) on July 15, 2026. The RSUs were credited in connection with a regular common stock dividend and represent non-cash equity compensation for a non-employee director.

How many Encompass Health (EHC) equity units does Greg D. Carmichael hold after this Form 4?

After the July 15, 2026 RSU award, Greg D. Carmichael is reported as holding 20,349 Encompass Health equity units directly. This total includes the newly credited 29 RSUs granted as a dividend-equivalent award linked to the company’s common stock dividend.

Why did Greg D. Carmichael receive 29 RSUs from Encompass Health (EHC)?

Carmichael received 29 RSUs under an arrangement where additional RSUs are credited to non-employee directors when Encompass Health pays dividends. The credited amount reflects his existing RSU balance, the $0.19 per-share dividend, and the $109.88 closing price on the payment date.

What dividend and price were used to calculate Greg D. Carmichael’s RSU award at Encompass Health (EHC)?

The RSU award was based on a common stock dividend of $0.19 per share and a closing price of $109.88 on July 15, 2026. These figures determine how many additional RSUs are credited to each non-employee director’s account.

Is Greg D. Carmichael’s Encompass Health (EHC) transaction a market purchase or sale?

The July 15, 2026 transaction is not a market purchase or sale. It is classified as a grant or award acquisition (code A), where 29 RSUs were automatically credited as dividend-equivalent compensation to a non-employee director’s account.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

CARMICHAEL GREG D

(Last) (First) (Middle)

9001 LIBERTY PARKWAY

(Street)

BIRMINGHAM ALABAMA 35242

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Encompass Health Corp [ EHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Encompass Health Common Stock	07/15/2026		A		29(1)	A	$0	20,349	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2026, Encompass Health paid a dividend on its common stock of $0.19 per share and the closing price was $109.88. The transaction reported on this Form 4 is an award of RSUs as sociated with that dividend payment.

	/s/ Patrick Darby, attorney-in-fact for Greg D. Carmichael	07/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)